Department of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan.
Division of General Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
J Infect Chemother. 2022 Jun;28(6):735-740. doi: 10.1016/j.jiac.2022.02.002. Epub 2022 Feb 9.
Safe vaccination worldwide is critical to end the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate adverse reactions to vaccination using a web-based questionnaire and examine the risk factors for the occurrence of immunisation stress-related response (ISRR).
We conducted a questionnaire survey using Google Form® among the employees of St. Marianna University Hospital who had received the COVID-19 vaccine between April 2021 and May 2021, 1 week after the first and second vaccinations. We developed and used a questionnaire to identify individuals with ISRR according to the World Health Organization diagnostic criteria. A generalised linear mixed model was constructed with ISRR onset as the dependent variable, subjects as the random factor, and each parameter as a fixed factor. A multivariate model was constructed using the forced imputation method with factors that were significant in the univariate analysis.
We enrolled 2,073 and 1,856 respondents in the first and second questionnaire surveys, respectively. Fifty-five and 33 ISRR cases were identified in the first and second vaccinations, respectively. In the univariate analysis, strong pre-vaccination anxiety (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.30-4.12, p = 0·004) and history of allergy (OR, 1.6; 95% CI, 1.14-2.24, p = 0·007) were significant risk factors. Multivariate analysis also showed that strong pre-vaccination anxiety (OR, 2.1; 95% CI, 1.15-3.80, p = 0.016) and history of allergy (OR, 1.5; 95% CI, 1.09-2.15, p = 0.014) were significant risk factors.
Confirmation of allergy prior to vaccination and subsequent action are essential for addressing ISRR.
全球安全接种对于终结 2019 年冠状病毒病(COVID-19)大流行至关重要。我们旨在使用基于网络的问卷评估接种疫苗后的不良反应,并研究免疫接种应激相关反应(ISRR)发生的风险因素。
我们使用 Google Form® 对 2021 年 4 月至 5 月期间在圣玛丽安娜大学医院接种 COVID-19 疫苗的员工进行了问卷调查,在第一和第二剂疫苗接种后一周进行。我们根据世界卫生组织的诊断标准制定并使用问卷来识别 ISRR 患者。使用广义线性混合模型,以 ISRR 发作作为因变量,以受试者作为随机因素,以每个参数作为固定因素。使用单变量分析中具有显著意义的因素,采用强制插补法构建多变量模型。
我们分别在第一次和第二次问卷调查中招募了 2073 名和 1856 名应答者。在第一次和第二次接种中,分别确定了 55 例和 33 例 ISRR 病例。在单变量分析中,强烈的接种前焦虑(比值比 [OR],2.3;95%置信区间 [CI],1.30-4.12,p=0.004)和过敏史(OR,1.6;95% CI,1.14-2.24,p=0.007)是显著的风险因素。多变量分析还显示,强烈的接种前焦虑(OR,2.1;95% CI,1.15-3.80,p=0.016)和过敏史(OR,1.5;95% CI,1.09-2.15,p=0.014)也是显著的风险因素。
在接种疫苗前确认过敏史并采取相应措施对于处理 ISRR 至关重要。